$GEG
Great Elm Group, Inc. Stock $geg

$geg Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000095017024124691 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$3.992M
YoY Change		20.6%
Cost Of Revenue		$635.0K
YoY Change		-77.32%
Gross Profit		$3.357M
YoY Change		571.4%
Gross Profit Margin		84.09%
Selling, General & Admin		$2.006M
YoY Change		16.97%
% of Gross Profit		59.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$273.0K
YoY Change		-3.53%
% of Gross Profit		8.13%
Operating Expenses		$5.353M
YoY Change		212.13%
Operating Profit		-$1.996M
YoY Change		37.66%
Interest Expense		$1.028M
YoY Change		-3.2%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		$2.974M
YoY Change		7.83%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings		$2.639M
YoY Change		-4.87%
Net Earnings / Revenue		66.11%
Basic Earnings Per Share		$0.09
Diluted Earnings Per Share		$0.08
COMMON SHARES
Basic Shares Outstanding	29.74M	31.88M
Diluted Shares Outstanding		40.47M

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$113.3M
YoY Change		-0.35%
Cash & Equivalents		$44.15M
Short-Term Investments		$66.93M
Other Short-Term Assets		$7.511M
YoY Change		25.18%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets		$124.7M
YoY Change		0.66%
LONG-TERM ASSETS
Property, Plant & Equipment		$141.0K
YoY Change		-64.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$1.682M
YoY Change		1076.22%
Total Long-Term Assets		$12.60M
YoY Change		1.64%
TOTAL ASSETS
Total Short-Term Assets		$124.7M
Total Long-Term Assets		$12.60M
Total Assets		$137.3M
YoY Change		0.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$243.0K
YoY Change		21.5%
Accrued Expenses		$3.353M
YoY Change		-14.03%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$224.0K
YoY Change		-81.33%
Total Short-Term Liabilities		$3.844M
YoY Change		-27.2%
LONG-TERM LIABILITIES
Long-Term Debt		$61.09M
YoY Change		-3.04%
Other Long-Term Liabilities		$718.0K
YoY Change		29.37%
Total Long-Term Liabilities		$718.0K
YoY Change		29.37%
TOTAL LIABILITIES
Total Short-Term Liabilities		$3.844M
Total Long-Term Liabilities		$718.0K
Total Liabilities		$65.68M
YoY Change		-4.7%
SHAREHOLDERS EQUITY
Retained Earnings		-$3.250B
YoY Change		0.05%
Common Stock		$28.00K
YoY Change		-6.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$63.90M
YoY Change
Total Liabilities & Shareholders Equity		$137.3M
YoY Change		0.75%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$2.639M
YoY Change		-4.87%
Depreciation, Depletion And Amortization		$273.0K
YoY Change		-3.53%
Cash From Operating Activities		-$5.787M
YoY Change		-5.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$148.0K
YoY Change		25.42%
Cash From Investing Activities		$2.491M
YoY Change		-119.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-2.232M
YoY Change
NET CHANGE
Cash From Operating Activities		-5.787M
Cash From Investing Activities		2.491M
Cash From Financing Activities		-2.232M
Net Change In Cash		-5.528M
YoY Change		-71.04%
FREE CASH FLOW
Cash From Operating Activities		-$5.787M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001831096
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	geg	Payable For Securities Purchased PayableForSecuritiesPurchased
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2024Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://www.greatelmgroup.com/20240930#RealizedAndUnrealizedGainLossOnInvestments
CY2023Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://www.greatelmgroup.com/20240930#RealizedAndUnrealizedGainLossOnInvestments
CY2024Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.greatelmgroup.com/20240930#RealizedAndUnrealizedGainLossOnInvestments
CY2023Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.greatelmgroup.com/20240930#RealizedAndUnrealizedGainLossOnInvestments
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	001-39832
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	Great Elm Group, Inc.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3622015
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	3801 PGA Boulevard
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 603
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Palm Beach Gardens
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33410
CY2024Q3	dei	City Area Code CityAreaCode	617
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	375-3006
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29743735
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44150000
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48147000
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	40000
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1571000
CY2024Q3	geg	Investments In Marketable Securities InvestmentsInMarketableSecurities	7460000
CY2024Q2	geg	Investments In Marketable Securities InvestmentsInMarketableSecurities	9929000
CY2024Q3	us-gaap	Investments Investments	47557000
CY2024Q2	us-gaap	Investments Investments	44585000
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1439000
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1215000
CY2024Q3	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	5786000
CY2024Q2	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	5769000
CY2024Q3	geg	Assets Of Consolidated Funds Cash And Cash Equivalents AssetsOfConsolidatedFundsCashAndCashEquivalents	2229000
CY2024Q2	geg	Assets Of Consolidated Funds Cash And Cash Equivalents AssetsOfConsolidatedFundsCashAndCashEquivalents	2371000
CY2024Q3	geg	Consolidated Investments Assets At Fair Value ConsolidatedInvestmentsAssetsAtFairValue	11909000
CY2024Q2	geg	Consolidated Investments Assets At Fair Value ConsolidatedInvestmentsAssetsAtFairValue	11471000
CY2024Q3	geg	Assets Of Consolidated Funds Other Assets AssetsOfConsolidatedFundsOtherAssets	246000
CY2024Q2	geg	Assets Of Consolidated Funds Other Assets AssetsOfConsolidatedFundsOtherAssets	253000
CY2024Q3	us-gaap	Assets Current AssetsCurrent	124670000
CY2024Q2	us-gaap	Assets Current AssetsCurrent	127570000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10773000
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11037000
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	141000
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	225000
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1682000
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1614000
CY2024Q3	us-gaap	Assets Assets	137266000
CY2024Q2	us-gaap	Assets Assets	140446000
CY2024Q3	geg	Payable For Securities Purchased PayableForSecuritiesPurchased	24000
CY2024Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3117000
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7009000
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64000
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	137000
CY2024Q3	geg	Payable For Securities Purchased Consolidated Funds PayableForSecuritiesPurchasedConsolidatedFunds	0
CY2024Q2	geg	Payable For Securities Purchased Consolidated Funds PayableForSecuritiesPurchasedConsolidatedFunds	100000
CY2024Q3	geg	Accrued Expenses And Other Consolidated Funds AccruedExpensesAndOtherConsolidatedFunds	172000
CY2024Q2	geg	Accrued Expenses And Other Consolidated Funds AccruedExpensesAndOtherConsolidatedFunds	162000
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3844000
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8359000
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	35000
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57000
CY2024Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	26945000
CY2024Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	26945000
CY2024Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	26160000
CY2024Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	26090000
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	35494000
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	35494000
CY2024Q3	geg	Convertible Notes Payable Held By Related Party Non Current ConvertibleNotesPayableHeldByRelatedPartyNonCurrent	16174000
CY2024Q2	geg	Convertible Notes Payable Held By Related Party Non Current ConvertibleNotesPayableHeldByRelatedPartyNonCurrent	16174000
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	34925000
CY2024Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	34900000
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	718000
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	845000
CY2024Q3	us-gaap	Liabilities Liabilities	65682000
CY2024Q2	us-gaap	Liabilities Liabilities	70251000
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32134843
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28743290
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31875285
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30494448
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	28000
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	30000
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3314191000
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3315638000
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3250315000
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3252954000
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	63904000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	62714000
CY2024Q3	us-gaap	Minority Interest MinorityInterest	7680000
CY2024Q2	us-gaap	Minority Interest MinorityInterest	7481000
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71584000
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	70195000
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	137266000
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	140446000
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3992000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3310000
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	635000
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	0
CY2024Q3	us-gaap	Management Fee Expense ManagementFeeExpense	3058000
CY2023Q3	us-gaap	Management Fee Expense ManagementFeeExpense	2762000
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	273000
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	283000
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2006000
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1715000
CY2024Q3	geg	Expenses Of Consolidated Funds ExpensesOfConsolidatedFunds	16000
CY2023Q3	geg	Expenses Of Consolidated Funds ExpensesOfConsolidatedFunds	0
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	5353000
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	4760000
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1996000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1450000
CY2024Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1558000
CY2023Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1986000
CY2024Q3	geg	Realized And Unrealized Gain Loss On Investments RealizedAndUnrealizedGainLossOnInvestments	3778000
CY2023Q3	geg	Realized And Unrealized Gain Loss On Investments RealizedAndUnrealizedGainLossOnInvestments	3284000
CY2024Q3	geg	Net Realized And Unrealized Gain Loss On Investments Of Consolidated Funds NetRealizedAndUnrealizedGainLossOnInvestmentsOfConsolidatedFunds	278000
CY2023Q3	geg	Net Realized And Unrealized Gain Loss On Investments Of Consolidated Funds NetRealizedAndUnrealizedGainLossOnInvestmentsOfConsolidatedFunds	0
CY2024Q3	geg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	384000
CY2023Q3	geg	Interest And Other Income Of Consolidated Funds InterestAndOtherIncomeOfConsolidatedFunds	0
CY2024Q3	us-gaap	Interest Expense InterestExpense	1028000
CY2023Q3	us-gaap	Interest Expense InterestExpense	1062000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2974000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2758000
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2024Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2974000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2758000
CY2024Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0
CY2023Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	16000
CY2024Q3	us-gaap	Profit Loss ProfitLoss	2974000
CY2023Q3	us-gaap	Profit Loss ProfitLoss	2774000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	335000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	0
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	2639000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	2774000
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29079000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29579000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40469000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41860000
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	70195000
CY2024Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	2974000
CY2024Q3	geg	Distributions From Consolidated Funds DistributionsFromConsolidatedFunds	-136000
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2109000
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	660000
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71584000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63842000
CY2023Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	2774000
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	705000
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67321000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2974000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2758000
CY2024Q3	geg	Gain Loss On Sale Of Real Estate GainLossOnSaleOfRealEstate	-12000
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	273000
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	283000
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	660000
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	705000
CY2024Q3	geg	Unrealized Gain Loss On Investments Including Investments Of Consolidated Fund UnrealizedGainLossOnInvestmentsIncludingInvestmentsOfConsolidatedFund	4370000
CY2023Q3	geg	Unrealized Gain Loss On Investments Including Investments Of Consolidated Fund UnrealizedGainLossOnInvestmentsIncludingInvestmentsOfConsolidatedFund	3372000
CY2024Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-592000
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-88000
CY2024Q3	geg	Non Cash Interest And Amortization Of Capitalized Issuance Costs NonCashInterestAndAmortizationOfCapitalizedIssuanceCosts	539000
CY2023Q3	geg	Non Cash Interest And Amortization Of Capitalized Issuance Costs NonCashInterestAndAmortizationOfCapitalizedIssuanceCosts	573000
CY2024Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-6000
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	18000
CY2024Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-730000
CY2023Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	207000
CY2024Q3	geg	Purchases Of Investments By Consolidated Fund PurchasesOfInvestmentsByConsolidatedFund	1496000
CY2024Q3	geg	Proceeds From Principal Payments Of Consolidated Funds ProceedsFromPrincipalPaymentsOfConsolidatedFunds	1257000
CY2024Q3	geg	Amortization Of Premium And Accretion Of Discount Net AmortizationOfPremiumAndAccretionOfDiscountNet	-21000
CY2024Q3	geg	Net Realized And Unrealized Gains Losses On Investments From Consolidated Funds NetRealizedAndUnrealizedGainsLossesOnInvestmentsFromConsolidatedFunds	278000
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	1595000
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	765000
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	153000
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2218000
CY2024Q3	geg	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	-15000
CY2023Q3	geg	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	-1408000
CY2024Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-11000
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8000
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-404000
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-1125000
CY2024Q3	geg	Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities	-4621000
CY2023Q3	geg	Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities	-1448000
CY2024Q3	geg	Increase Decrease In Cash And Cash Equivalents From Consolidated Funds IncreaseDecreaseInCashAndCashEquivalentsFromConsolidatedFunds	-142000
CY2024Q3	geg	Increase Decrease In Other Operating Assets Of Consolidated Funds IncreaseDecreaseInOtherOperatingAssetsOfConsolidatedFunds	-7000
CY2024Q3	geg	Increase Decrease In Accrued Expenses And Other Liabilities IncreaseDecreaseInAccruedExpensesAndOtherLiabilities	-3000
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5787000
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6126000
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5787000
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6126000
CY2024Q3	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	7378000
CY2023Q3	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	9801000
CY2024Q3	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	10000000
CY2023Q3	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4476000
CY2024Q3	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4000
CY2024Q3	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	13000
CY2023Q3	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1793000
CY2024Q3	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	148000
CY2023Q3	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	118000
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	2491000
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-12602000
CY2023Q3	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-360000
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2491000
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12962000
CY2024Q3	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	123000
CY2024Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2109000
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2232000
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2232000
CY2024Q3	geg	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Cash And Cash Equivalents Classified Within Current Assets Held For Sale CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingCashAndCashEquivalentsClassifiedWithinCurrentAssetsHeldForSale	-5528000
CY2023Q3	geg	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Cash And Cash Equivalents Classified Within Current Assets Held For Sale CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingCashAndCashEquivalentsClassifiedWithinCurrentAssetsHeldForSale	-19088000
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5528000
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19088000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49718000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	60165000
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44190000
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41077000
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	488000
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	488000
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44150000
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48147000
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	40000
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1571000
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44190000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49718000
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">US GAAP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. On an on-going basis, the Company evaluates all of these estimates and assumptions. The most important of these estimates and assumptions relate to revenue recognition, valuation allowance for deferred tax assets, estimates associated with accounting for asset acquisitions, and fair value measurements, including stock-based compensation. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although these and other estimates and assumptions are based on the best available information, actual results could be different from these estimates.</span></p>
CY2024Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2974000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2758000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	335000
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2639000
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2758000
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	16000
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	16000
CY2024Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	470000
CY2023Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	503000
CY2024Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	3109000
CY2023Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	3261000
CY2024Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	0
CY2023Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	16000
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29079000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29579000
CY2024Q3	geg	Incremental Common Shares Attributable To Restricted Stock IncrementalCommonSharesAttributableToRestrictedStock	1168000
CY2023Q3	geg	Incremental Common Shares Attributable To Restricted Stock IncrementalCommonSharesAttributableToRestrictedStock	1363000
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	10222000
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	10918000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40469000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41860000
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3104424
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3264424
CY2024Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1167705
CY2023Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1362723
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3992000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3310000
CY2024Q3	geg	Incentive Fee Earned As Percentage On Investment Performance IncentiveFeeEarnedAsPercentageOnInvestmentPerformance	0.20
CY2024Q3	geg	Incentive Fee Earned Based On Investment Performance IncentiveFeeEarnedBasedOnInvestmentPerformance	900000
CY2024Q3	geg	Fair Value Liabilities Level2 To Level1 Transfer Amount FairValueLiabilitiesLevel2ToLevel1TransferAmount	0
CY2023Q3	geg	Fair Value Liabilities Level2 To Level1 Transfer Amount FairValueLiabilitiesLevel2ToLevel1TransferAmount	0
CY2024Q3	geg	Fair Value Liabilities Level1 To Level2 Transfer Amount FairValueLiabilitiesLevel1ToLevel2TransferAmount	0
CY2023Q3	geg	Fair Value Liabilities Level1 To Level2 Transfer Amount FairValueLiabilitiesLevel1ToLevel2TransferAmount	0
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	55017000
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	54514000
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	428000
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	428000
CY2024Q3	geg	Fair Value Assets Level1 To Level2 Transfer Amount FairValueAssetsLevel1ToLevel2TransferAmount	0
CY2024Q3	geg	Fair Value Assets Level2 To Level1 Transfer Amount FairValueAssetsLevel2ToLevel1TransferAmount	0
CY2023Q3	geg	Fair Value Assets Level1 To Level2 Transfer Amount FairValueAssetsLevel1ToLevel2TransferAmount	0
CY2023Q3	geg	Fair Value Assets Level2 To Level1 Transfer Amount FairValueAssetsLevel2ToLevel1TransferAmount	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	5265000
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	0
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	3479000
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	8744000
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
CY2024Q3	geg	Fair Value Assets Level1 To Level2 Transfer Amount FairValueAssetsLevel1ToLevel2TransferAmount	0
CY2024Q3	geg	Change In Unrealized Gain Loss ChangeInUnrealizedGainLoss	3500000
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	428000
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1903000
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	422000
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	977000
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-6000
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	18000
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	944000
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2024Q3	geg	Capitalized Cost Within Real Estate Under Development Current CapitalizedCostWithinRealEstateUnderDevelopmentCurrent	17000
CY2023Q3	geg	Capitalized Cost Within Real Estate Under Development Current CapitalizedCostWithinRealEstateUnderDevelopmentCurrent	1400000
CY2024Q3	geg	Number Of Identifiable Real Estate Projects NumberOfIdentifiableRealEstateProjects	2
CY2024Q2	geg	Sale On Assets For Consideration SaleOnAssetsForConsideration	7800000
CY2024Q3	geg	Percentage Of Estimates Construction Complete PercentageOfEstimatesConstructionComplete	0.926
CY2024Q3	us-gaap	Interest Expense Other InterestExpenseOther	600000
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	600000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3264000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.7
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M8D
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	160000
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.52
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3104000
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.6
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1104000
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.61
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M3D
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	8900000
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000950170-24-124691-index-headers.html	Edgar Link	pending
0000950170-24-124691-index.html	Edgar Link	pending
0000950170-24-124691.txt	Edgar Link	pending
0000950170-24-124691-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
geg-20240930.htm	Edgar Link	pending
geg-20240930.xsd	Edgar Link	pending
geg-ex31_1.htm	Edgar Link	pending
geg-ex31_2.htm	Edgar Link	pending
geg-ex32_1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
geg-20240930_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GEG
Great Elm Group, Inc. Stock $geg

2024 Q4 Form 10-Q Financial Statement

#000095017024124691 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GEG Great Elm Group, Inc. Stock $geg

2024 Q4 Form 10-Q Financial Statement

#000095017024124691 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GEG
Great Elm Group, Inc. Stock $geg